论文部分内容阅读
对２０例丙型病毒性肝炎患者用重组α－２ｂ干扰素治疗，观察其近、远期疗效，发现干扰素对丙型病毒性肝炎有效。治疗３个月（一疗程）后，６０％的患者丙型肝炎病毒（ＨＣＶ）ＲＮＡ转阴，８８．９％的患者肝功能恢复正常，但停药后其中部分患者ＨＣＶＲＮＡ又出现阳性，肝功能出现反复。随访１～２ａ，发现肝功能稳定正常者占５２．６％，ＨＣＶＲＮＡ持续阴转者占３１．６％。用干扰素治疗的丙型肝炎患者，凡早出现临床症状者，预后佳；ＨＣＶＲＮＡ持续阴转者，不易复发，病情稳定。
In 20 cases of hepatitis C patients with recombinant interferon α-2b treatment, to observe the short-term and long-term efficacy and found that interferon on hepatitis C effective. After 3 months of treatment (one course of treatment), HCV RNA was negative in 60% of patients and normal liver function was restored in 88.9% of patients, but HCVRNA was positive in some of the patients after stopping treatment. Liver function Appear repeatedly. Follow-up 1 ~ 2a, found that stable and normal liver function accounted for 52.6%, HCVRNA persistent overcast accounted for 31.6%. Hepatitis C patients treated with interferon, who had early clinical symptoms, a good prognosis; HCVRNA persistent overcast, not easy to relapse, stable condition.